Vivani Medical manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence. It creates a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa. Through dedication and innovation, Second Sight's mission is to develop, manufacture, and market implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight Medical Products located in Sylmar, California, and was founded in 1998.

Cortigent, Inc. engages in developing targeted neurostimulation systems to help patients recover critical body functions. The company was founded in November 2022 and is headquartered in Valencia, CA.

Doheny Eye Institute is an American private company located in Los Angeles, CA. The firm provides eye care related research and education programs. Marissa Goldberg is currently the CEO of the company.\nThe company says this about itself: For more than 70 years, Doheny Eye Institute has been at the forefront of vision science. From seeking new ways to free blockages that prevent fluid drainage in glaucoma, to replacing retinal cells in age-related macular degeneration, to providing colleagues worldwide with standardized analyses of anatomical changes in the eyes of patients, Doheny clinician-scientists and researchers are changing how people see �� and also how they think about the future of vision. Doheny Eye Institute and UCLA Stein Eye Institute have joined forces to offer the best patient care, vision research, and education. This affiliation combines the strength, reputation, and distinction of two of the nation's top eye institutions to advance vision research, education, and patient care in California.

Pixium Vision is developing retinal implant systems for patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The Company intends to harness the rapid advances being made in neural processing, micro-electronics and computing to develop retinal implant systems that for blind people could ultimately provide vision approaching that of a normal healthy Pixium's first device, IRIS1 (Intelligent Retinal Implantable System), uses an epi-retinal implant (on the retinal surface) and is currently in clinical trials with the goal of obtaining CE Mark. A second generation system (IRIS2) based on the same format, but offering better visual acuity and featuring several breakthrough technologies, is also under development. In addition, Pixium is developing a sub-retinal implant system (IRIS3), based on further technological breakthroughs, which has the potential to improve vision significantly compared to IRIS1 and IRIS2. Pixium was created in Paris, France in November 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie, and based on collaborative work involving several leading academic teams across Europe. Pixium is backed by a syndicate of blue-chip European venture capital firms including Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Seventure and Polytechnos.

IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees.\nThe company has a process oriented quality management system in accordance with ISO 13485.

Weizhi Medical Equipment Co., Ltd., established on 2018-03-26, Business scope includes prosthetics,artificial organs and implants(between)into device manufacturing;Prosthetics and Orthotics(assistive devices)production assembly;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Class III Medical Devices,Production of Class II Medical Devices;Class III Medical Devices,Sales of Class II Medical Devices;Class III Medical Devices,R&D of Class II medical devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Precision Neuroscience Corp. is a company headquartered in New York, NY, that develops brain-computer interface technology platform. The firm was founded by Rapoport Benjamin, Michael Mager, Papageorgiou Demetrios and Mark Hettick. Michael Mager is currently the CEO of the company.\nThe company says this about itself: Precision Neuroscience is working to provide breakthrough treatments for the millions of people worldwide suffering from neurological illnesses. The company is building the only brain?computer interface designed to be minimally invasive, safely removable, and capable of processing large amounts of data.

Advanced Medical Electronics is a product-focused research and development company specializing in medical devices.

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

Institut de Física d’Altes Energies is a research institute that provides education and research in physics, cosmology, and astrophysics.

AD Verwaltungs GmbH & Co. KG is a German private company located in Gr��nwald. The firm provides management services.

Beijing Dashiming Technology Development Co., Ltd., established on 2016-08-09, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Basic software service;Application software service;software development;software consulting;product design;model design;design,make,acting,Place an ad;Undertake exhibition and display activities;Conference Services;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Sell ​​self-developed products.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Taiyuan Aier Ophthalmic Hospital is a new modern chain ophthalmic hospital invested and established in Taiyuan by Aier Ophthalmic Hospital Group, a global chain ophthalmic medical group and an IPO listed medical institution, which integrates clinical, scientific research and teaching. It is a secondary ophthalmic hospital directly under Taiyuan City. It has carried out diagnosis and treatment projects for myopia correction, cataract, glaucoma, fundus disease, strabismus and amblyopia, pediatric ophthalmopathy, keratopathy, eye plastic surgery, medical optometry and glasses, equipped with advanced inspection and surgical equipment, and has a skilled medical team, committed to providing professional and high-quality diagnosis and treatment services for eye patients. Among them, the refractive department is the key department of Aier Eye · Taiyuan Hospital, and is also the designated operating agency of Shanxi Police College. At present, tens of thousands of myopia correction operations have been successfully completed. Chen Peng, a myopic surgery expert who has been engaged in myopia surgery for more than 20 years, is the leader of the department. The department attaches importance to the exchange and improvement of surgical technology, constantly introduces international advanced inspection and surgical equipment, and takes the lead in introducing Zeiss all femtosecond laser surgery system from Germany, corneal collagen accelerated cross-linking system from Avedro from the United States and other leading surgical instruments in Shanxi Province, which can carry out excimer, femtosecond Full femtosecond laser myopia correction surgery and ICL lens implantation for high myopia patients. In addition, corneal cross-linking can also be carried out for keratoconus patients and patients with thin corneas, which can not only help myopic friends achieve their desire to take off the lens, but also bring effective treatment for keratoconus patients and avoid the risk of corneal transplantation. After several years of development, the refractive department has won recognition and praise from myopia friends with its advanced diagnosis and treatment equipment, professional diagnosis and treatment technology, scientific diagnosis and treatment program, and high-quality diagnosis and treatment services. Tel.: 0351-2792999 Address: No. 1, Nanneihuan Street, Taiyuan City (intersection with Jianshe Road)

Johns Hopkins Technology Ventures (JHTV) is the University’s intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent, and technology commercialization office and acting as an active liaison to parties interested in leveraging JHU research or materials for academic or corporate endeavors.

Part of NXP Semiconductors NV, NXP Semiconductors (Thailand) Co., Ltd. is a company headquartered in Bangkok, Thailand. The firm manufactures semiconductors and related devices.

Shanghai Huashi Investment Co. Ltd. is a company headquartered in China that provides investment services.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Greatbatch Ltd. develops and manufactures medical devices and components. It specializes in Cardiac Rhythm Management, Neuromodulation, Vascular and Orthopedics. The company was founded on February 5, 1970 and is headquartered in Clarence, NY.

Nanjing Huamai Robot Technology Co., Ltd., established on 2020-07-17, Business scope includes general items:IoT Device Sales;IoT application service;Internet of Things Technology Services;Intelligent robot sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Network Equipment Sales;Network technology service;Information system integration service;Information Technology Consulting Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) Limited to branch operations:IoT device manufacturing;Communication equipment manufacturing;Network equipment manufacturing